While mycophenolate mofetil is standard of care treatment for lupus nephritis, belimumab might be an alternative.

Deucravacitinib reduces circulating proteins associated with kidney dysfunction in patients with systemic lupus erythematosus, according to data presented at ACR Convergence 2025.“Specific plasma ...

A 20-year analysis finds persistent racial disparities in kidney transplant outcomes among lupus patients, with higher graft ...

Introduction Chronic kidney disease (CKD) affects 1 in 10 people worldwide and can progress towards kidney failure, which is ...

Common recommendations are to start HCQ treatment with doses of 200 mg or 400 mg per day. Some formulas suggest a weight-based approach, at 6.5 mg/kg, adjusted to take account of the fact that HCQ ...

The Lupus Foundation of America (LFA) proudly presented eight abstracts and sessions during the 2025 American College of Rheumatology (ACR) Convergence with the goal of advancing science, improving ...

The current recommended urine protein to creatinine ratio is arbitrary, and a lower bar would capture more lupus nephritis ...

CLN-978 led to rapid and deep B cell depletion in vitro and in vivo in multiple autoimmune diseasesCAMBRIDGE, Mass., (GLOBE ...

MRT-6160 inhibited disease pathology, including proteinuria, lymphadenopathy, skin lesion formation, autoantibody production, and organomegaly, in a spontaneous autoimmune disease mouse model Data ...

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, announced today the acceptance of six abstracts at the 2025 American College of Rheumatology’s (ACR) annual meeting, ACR ...

Results of a Phase 2a dose escalating study of lingdolinurad (ABP-671) for chronic gout, which enrolled patients with mild to moderate renal impairment, showed the URAT1 inhibitor lowered serum uric ...

WICHITA, Kan. (KWCH) - With 17% of Kansas Medicare patients living with chronic kidney disease, and nearly 150 waiting for lifesaving transplants, the Annual Kidney Walk held in Wichita on Sunday ...